Clinical Trials

Sponsor: NRG

Sponsor Study ID: NRG-CC012CD

Study Title: NRG-CC012CD: Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment (Symon)

CTO #: 104121

NCT Number: NCT06279013

Phase: N/A

Protocol Type: Supportive Care

Age Group: Adults

Disease Sites:

Study Objectives: Test the effectiveness of automated telephone system management (ATSM) + telephone interpersonal counseling (TIPC) versus active control on patient level outcome of the summary toxicity index of 24 PRO-CTCAE symptoms that include depressive, anxiety, and other symptoms commonly experienced during oral anti-cancer treatment over weeks 1-12 (immediate effect) and 13-17 (sustained effect).



Study Documents    
(MUSC NetID required for document access)